Ironwood Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.58M Buy
87,472
+3,912
+5% +$375K 1.09% 22
2025
Q4
$8.03M Buy
83,560
+1,061
+1% +$103K 1.12% 22
2025
Q3
$7.86M Buy
82,499
+2,029
+3% +$187K 1.15% 21
2025
Q2
$7.01M Buy
80,470
+2,634
+3% +$223K 1.08% 25
2025
Q1
$6.99M Buy
77,836
+4,424
+6% +$396K 1.21% 18
2024
Q4
$5.86M Sell
73,412
-637
-0.9% -$55.1K 1% 27
2024
Q3
$6.67M Buy
74,049
+1,544
+2% +$130K 1.11% 23
2024
Q2
$5.71M Buy
72,505
+1,484
+2% +$122K 1.02% 27
2024
Q1
$6.19M Buy
71,021
+2,228
+3% +$190K 1.08% 27
2023
Q4
$5.67M Buy
68,793
+1,620
+2% +$123K 1.06% 28
2023
Q3
$5.26M Buy
67,173
+6,609
+11% +$553K 1.11% 25
2023
Q2
$5.34M Buy
60,564
+12,107
+25% +$1.04M 1.2% 24
2023
Q1
$3.91M Buy
48,457
+5,637
+13% +$459K 0.93% 37
2022
Q4
$3.33M Buy
42,820
+336
+0.8% +$27.2K 0.81% 45
2022
Q3
$3.43M Buy
42,484
+4,544
+12% +$408K 0.98% 33
2022
Q2
$3.4M Buy
37,940
+2,505
+7% +$254K 0.96% 31
2022
Q1
$3.93M Buy
35,435
+4,066
+13% +$430K 0.97% 32
2021
Q4
$3.25M Buy
31,369
+2,383
+8% +$276K 0.74% 44
2021
Q3
$3.63M Buy
28,986
+746
+3% +$96.6K 0.93% 36
2021
Q2
$3.5M Buy
28,240
+4,995
+21% +$627K 0.93% 35
2021
Q1
$2.75M Sell
23,245
-16,291
-41% -$1.91M 0.79% 41
2020
Q4
$4.63M Buy
39,536
+3,231
+9% +$356K 1.05% 32
2020
Q3
$3.77M Buy
36,305
+3,922
+12% +$394K 1.02% 31
2020
Q2
$2.97M Buy
32,383
+2,840
+10% +$272K 0.91% 35
2020
Q1
$2.66M Buy
29,543
+1,450
+5% +$154K 1.05% 31
2019
Q4
$3.19M Buy
28,093
+953
+4% +$105K 1.09% 30
2019
Q3
$2.95M Sell
27,140
-2,433
-8% -$254K 1.09% 29
2019
Q2
$2.88M Buy
29,573
+664
+2% +$60.6K 1.1% 30
2019
Q1
$2.63M Sell
28,909
-790
-3% -$70.7K 1.04% 31
2018
Q4
$2.7M Sell
29,699
-987
-3% -$92.2K 1.19% 31
2018
Q3
$3.02M Sell
30,686
-119
-0.4% -$11K 1.17% 31
2018
Q2
$2.64M Sell
30,805
-1,076
-3% -$89.9K 1.15% 31
2018
Q1
$2.56M Sell
31,881
-378
-1% -$31.2K 1.14% 32
2017
Q4
$2.6M Buy
32,259
+685
+2% +$54.9K 0.96% 33
2017
Q3
$2.46M Buy
31,574
+370
+1% +$30.7K 0.99% 31
2017
Q2
$2.77M Buy
31,204
+1,044
+3% +$88K 1.04% 26
2017
Q1
$2.43M Buy
30,160
+794
+3% +$62K 1.02% 30
2016
Q4
$2.09M Buy
29,366
+57
+0.2% +$4.48K 0.93% 33
2016
Q3
$2.53M Sell
29,309
-5,659
-16% -$493K 1.18% 26
2016
Q2
$3.03M Buy
34,968
+5,847
+20% +$473K 1.77% 15
2016
Q1
$2.18M Buy
29,121
+3,037
+12% +$229K 1.14% 29
2015
Q4
$2.01M Sell
26,084
-574
-2% -$43.2K 1.15% 30
2015
Q3
$1.78M Sell
26,658
-9,560
-26% -$704K 0.97% 34
2015
Q2
$2.68M Sell
36,218
-664
-2% -$50.7K 1.36% 21
2015
Q1
$2.88M Sell
36,882
-11,059
-23% -$838K 1.46% 20
2014
Q4
$3.46M Sell
47,941
-577
-1% -$40.1K 1.75% 12
2014
Q3
$3.01M Sell
48,518
-725
-1% -$46.1K 1.6% 17
2014
Q2
$3.14M Sell
49,243
-8,053
-14% -$489K 1.62% 17
2014
Q1
$3.53M Sell
57,296
-801
-1% -$46.7K 1.92% 9
2013
Q4
$3.33M Sell
58,097
-1,857
-3% -$105K 1.89% 12
2013
Q3
$3.19M Sell
59,954
-996
-2% -$53.6K 2.11% 11
2013
Q2
$3.14M Buy
+60,950
New +$3.01M 2.03% 12

Other funds holding MDT

Ironwood Investment Counsel's MDT Position: Q1 2026 in Review

Ironwood Investment Counsel increased its Medtronic (MDT) stake by 4.7% in Q1 2026, buying an estimated $375K and bringing the position to 87,472 shares worth $7.58M. The position accounts for 1.09% of the portfolio, ranked #22.

Ironwood Investment Counsel first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.03M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Ironwood Investment Counsel held 87,472 shares of Medtronic worth $7.58M as of Q1 2026.
  • Ironwood Investment Counsel bought 3,912 Medtronic shares in Q1 2026, an estimated $375K.
  • Medtronic made up 1.09% of Ironwood Investment Counsel's portfolio in Q1 2026, its #22 holding.
  • Ironwood Investment Counsel first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Ironwood Investment Counsel's Medtronic position peaked at $8.03M in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Ironwood Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.